Story perspectives
Thermo Fisher Faces $900M Loss Amid Revenue Struggles
4/28/2025
34 6
1 of 1
Story summary
- Thermo Fisher and Danaher are experiencing revenue challenges due to tariffs and NIH funding cuts.
- Thermo Fisher anticipates a $400 million loss from tariffs and $500 million from academic and government customers.
- Danaher reported a 12% decline in net earnings but upheld its revenue forecasts amid softening U.S. academic demand.
- Following the results, Thermo Fisher's stock decreased by 2.4%, while Danaher's rose nearly 7%.
